Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRO: Mirabegron for Overactive Bladder in Parkinson's Disease
NCT02092181Phase 4Completed
- Start
- Mar 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron in overactive bladder (OAB). Started Mar 2014; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT02092181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092181.